Launch Decisions of Pharmaceutical Companies

Journal Title: Journal of Economics and Financial Analysis - Year 2017, Vol 1, Issue 1

Abstract

This paper models the launch decision of pharmaceutical companies in regard to new drugs and country markets. New drugs are launched with a delay or not launched at all in many countries. Considering that many of these new drugs would have created health benefits to the patients, there seems to be welfare loss. We use market characteristics to explain this phenomenon. We show that most of the estimated launch with a delay and no-launch decision is due to observable market characteristics. The model has an accuracy of 70 percent in explaining the no-launch decision. Intellectual property rights protection is especially important. The policy implication is that stronger property rights increase the likelihood and speed of new drug launch.

Authors and Affiliations

Abdulkadir Civan, Michael Maloney

Keywords

Related Articles

Financial Contagion in the BRICS Stock Markets: An empirical analysis of the Lehman Brothers Collapse and European Sovereign Debt Crisis

This research analyzes and extends the study of contagion for BRICS emerging stock markets in the context of the last two international financial crises: the Lehman Brothers Bankruptcy Crisis and the European Sovereign D...

A Modified Risk Parity Method for Asset Allocation

We propose a return based modification of the portfolio variance matrix for asset allocation using risk parity. The modification is based upon a single scalar parameter which can be tuned to tailor the allocation for des...

Determinants of Industrial Production in Turkey

The necessity of emphasizing the importance of industrial production for the sustainable growth and development of Turkey has been a topic of discussion in political and academia circles. The growth in industrial product...

Implication of Credit Supervision Practices on Portfolio at risk of Microfinance Institutions in Tanzania

This study seeks to establish the implication of credit supervision practices on portfolio management of microfinance institutions in Tanzania. Utilizing multivariate regression technique over sampled 219 microfinance in...

Nonprofit Organizations in Disaster Response and Management: A Network Analysis

This paper tracks changes in the national disaster management system with regard to the nonprofit sector by looking at the roles ascribed to nonprofit organizations in the Federal Response Plan (FRP), National Response P...

Download PDF file
  • EP ID EP246290
  • DOI -
  • Views 124
  • Downloads 0

How To Cite

Abdulkadir Civan, Michael Maloney (2017). Launch Decisions of Pharmaceutical Companies. Journal of Economics and Financial Analysis, 1(1), 35-58. https://www.europub.co.uk/articles/-A-246290